D46.9
BillableMyelodysplastic syndrome, unspecified
Myelodysplastic syndrome, unspecified
Coding Notes
Inclusion Terms
Alternative clinical terms for this condition
- Myelodysplasia NOS
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
- neoplasms of unspecified behavior (D49.-)
Excludes 2
Conditions not included here, but the patient may have both
- drug-induced aplastic anemia (D61.1)
Use Additional Code
Additional codes that should follow this code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Also Known As / Clinical Terms
SNOMED CT
- CAH - Congenital adrenal hypoplasia93235007
- Congenital adrenal hypoplasia93235007
- Congenital hypoplasia of adrenal gland93235007
- Congenital small adrenal gland93235007
- MDS - Myelodysplastic syndrome109995007
- Myelodysplastic syndrome109995007
- Myelodysplastic syndrome (clinical)109995007
- Haematologic complication of procedure363135008
- Hematologic complication of procedure363135008
- Therapy-related myelodysplastic syndrome702476004
- Childhood myelodysplastic syndrome705061009
- Therapy related acute myeloid leukaemia and myelodysplastic syndrome721306009
- Therapy related acute myeloid leukemia and myelodysplastic syndrome721306009
- Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent762315004
- Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent762315004
- Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent766045006
- Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent766045006
- Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor766046007
- Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type II inhibitor766046007
- Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor766046007
- Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type II inhibitor766046007
- Acute myeloid leukaemia and myelodysplastic syndrome related to radiation766048008
- Acute myeloid leukemia and myelodysplastic syndrome related to radiation766048008
- MIRAGE (myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital anomalies, enteropathy) syndrome1234831009
- MIRAGE syndrome1234831009
- Myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital anomalies, enteropathy syndrome1234831009
- Myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital phenotypes, enteropathy syndrome1234831009
- Disorder of bone marrow caused by ionising radiation1339017006
- Disorder of bone marrow caused by ionizing radiation1339017006
- Short stature co-occurrent and due to endocrine disorder368331000119100
UMLS
- DysmyelopoiesisC3463824
- Dysmyelopoietic SyndromeC3463824
- Dysmyelopoietic SyndromesC3463824
- Dysmyelopoietic syndromeC3463824
- MDNC3463824
- MDSC3463824
- MDS - Myelodysplastic syndromeC3463824
- MYELODYSPLASTIC SYNDROMEC3463824
- MyelodysplasiaC3463824
- Myelodysplastic NeoplasmC3463824
- Myelodysplastic SyndromeC3463824
- Myelodysplastic Syndrome/NeoplasmC3463824
- Myelodysplastic SyndromesC3463824
- Myelodysplastic neoplasmC3463824
- Myelodysplastic neoplasm (morphologic abnormality)C3463824
- Myelodysplastic syndromeC3463824
- Myelodysplastic syndrome (MDS)C3463824
- Myelodysplastic syndrome (clinical)C3463824
- Myelodysplastic syndrome (disorder)C3463824
- Myelodysplastic syndrome NOSC3463824
- Myelodysplastic syndrome, unspecifiedC3463824
- Myelodysplastic syndromesC3463824
- Myeloid dysplasiaC3463824
- Oligoblastic LeukemiaC3463824
- Smoldering LeukemiaC3463824
- Syndrome, DysmyelopoieticC3463824
- Syndrome, MyelodysplasticC3463824
- Syndromes, DysmyelopoieticC3463824
- Syndromes, MyelodysplasticC3463824
- myelodysplastic syndromeC3463824
- myelodysplastic syndromesC3463824
- myeloid dysplasiaC3463824
- Myelodysplasia NOSC0026985
- defective spinal cord developmentC0026985
- myelodysplasiaC0026985
- myelodysplasiasC0026985
Frequently Asked Questions
What is ICD-10 code D46.9?
ICD-10-CM code D46.9 represents "Myelodysplastic syndrome, unspecified". It is a billable/specific code that can be used on a claim.
Is D46.9 a billable code?
Yes, D46.9 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is D46.9 in?
D46.9 is in Chapter 2: Neoplasms (codes C00-D49).
What codes cannot be used with D46.9?
D46.9 has Excludes1 notes indicating codes that cannot be used together with it, including: neoplasms of unspecified behavior (D49.-).
Are additional codes required with D46.9?
Yes, when using D46.9 you should also code: code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5).
What SNOMED CT codes does D46.9 map to?
D46.9 maps to 13 SNOMED CT concepts: 766045006, 766048008, 766046007, 93235007, 705061009, and 8 more. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for D46.9?
D46.9 is linked to 2 UMLS Concept Unique Identifiers: C3463824, C0026985. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.